Literature DB >> 22085717

Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex.

Bogyou Kim1, Hye Jin Nam, Ki Eun Pyo, Min Jung Jang, Ik Soo Kim, Dongha Kim, Kyungjin Boo, Seung Hoon Lee, Jong-Bok Yoon, Sung Hee Baek, Jung Hwa Kim.   

Abstract

Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis without affecting primary tumorigenesis. The regulatory mechanism of BRMS1 at the protein level has not been revealed until recently. Here, we found that cullin 3 (Cul3), a component of E3 ubiquitin ligase, is a new binding partner of BRMS1 and the interaction between BRMS1 and Cul3 is mediated by the SPOP adaptor protein. Intriguingly, BRMS1 turns out to be a potent substrate that is ubiquitinated by the Cul3-SPOP complex. Knockdown of SPOP increases the level of BRMS1 protein and represses the expression of BRMS1 repressive target genes such as OPN and uPA in breast cancer cells. These results suggest that the novel regulatory mechanism of BRMS1 by Cul3-SPOP complex is important for breast cancer progression.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22085717     DOI: 10.1016/j.bbrc.2011.10.154

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Epigenetic Regulation in Breast Cancer.

Authors:  Hye Jin Nam; Sung Hee Baek
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Speckle-type POZ protein, SPOP, is involved in the DNA damage response.

Authors:  Dan Zhang; Haibo Wang; Mianen Sun; Jun Yang; Wei Zhang; Suxia Han; Bo Xu
Journal:  Carcinogenesis       Date:  2014-01-22       Impact factor: 4.944

Review 3.  Functional analysis of Cullin 3 E3 ligases in tumorigenesis.

Authors:  Ji Cheng; Jianping Guo; Zhiwei Wang; Brian J North; Kaixiong Tao; Xiangpeng Dai; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-11-08       Impact factor: 10.680

4.  CK2α' Drives Lung Cancer Metastasis by Targeting BRMS1 Nuclear Export and Degradation.

Authors:  Yuan Liu; Elianna B Amin; Marty W Mayo; Neel P Chudgar; Peter R Bucciarelli; Kyuichi Kadota; Prasad S Adusumilli; David R Jones
Journal:  Cancer Res       Date:  2016-03-15       Impact factor: 12.701

5.  SPOP regulates the DNA damage response and lung adenocarcinoma cell response to radiation.

Authors:  Yiping Dong; Dan Zhang; Mengjiao Cai; Zhenzhen Luo; Yue Zhu; Liuyun Gong; Yutiantian Lei; Xinyue Tan; Qing Zhu; Suxia Han
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

Review 6.  MiR-139-5p: promising biomarker for cancer.

Authors:  He-da Zhang; Lin-hong Jiang; Da-wei Sun; Jian Li; Jin-hai Tang
Journal:  Tumour Biol       Date:  2015-02-19

Review 7.  SPOP and cancer: a systematic review.

Authors:  Alison Clark; Marieke Burleson
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

Review 8.  The emerging role of speckle-type POZ protein (SPOP) in cancer development.

Authors:  Ram-Shankar Mani
Journal:  Drug Discov Today       Date:  2014-07-21       Impact factor: 7.851

9.  Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration.

Authors:  Siti Nur Ain Roesley; Randy Suryadinata; Emma Morrish; Anthonius Ricardo Tan; Samah M A Issa; Jonathan S Oakhill; Ora Bernard; Danny R Welch; Boris Šarčević
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

Review 10.  The ubiquitin ligase adaptor SPOP in cancer.

Authors:  Matthew J Cuneo; Tanja Mittag
Journal:  FEBS J       Date:  2019-09-18       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.